Lv1
70 积分 2023-04-18 加入
KDM6B-mediated reprogramming of myeloid cells regulates the response to immunotherapy
23天前
已完结
Myeloid-derived suppressor cells coming of age
26天前
已完结
Discovery and optimization of 4-anilinoquinazoline derivatives spanning ATP binding site and allosteric site as effective EGFR-C797S inhibitors
1个月前
已完结
Discovery of pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as novel non-covalent Bruton’s tyrosine kinase (BTK) inhibitors
1个月前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
1个月前
已完结
Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy
1个月前
已完结
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
1个月前
已完结
A molecular perspective for the use of type IV tyrosine kinase inhibitors as anticancer therapeutics
2个月前
已完结
Immune regulation by monocytes
2个月前
已完结
BTK inhibitors: past, present, and future
3个月前
已完结
皖公网安备34019202002308
